I genuinely can't comment on the rejection point - it had occurred to me, but it's not a point that's raised often in respect of hESC, so my general impression is that the risk isn't so huge. Don't know. If any medical types here can settle it either way, that'd be a good thing.
As for the other stuff: I disagree. The danger with using the patient's own cells is not the risk of blindness - it's the more general risk associated with any operation: anaesthetic risk mainly, but a whole host of other stuff (including, if you insist, the mere worry about having a second operation). With embryonic cells, all that is avoided, so to subject the patient to those risks seems arbitrary, unwarranted and therefore not morally straightforward. Wouldn't there be a greater chance of failure, too, if you're using cells from the very organ you're trying to cure? This would also speak to your specialisation point. Finally, I don't think that specialisation ought to be all that big a worry: for one thing, it doesn't take long for stem cells to specialise; for another, there might well be something to be said for having them unspecialised to begin with to allow a bit of adaptive flexibility when the graft is made.
Nope. I'm not a biologist either. I have a disappointing GCSE in physics, and that's as far as my scientific education goes.
(, Thu 4 Jun 2009, 8:40, Reply)